JP2021502120A5 - - Google Patents
Info
- Publication number
- JP2021502120A5 JP2021502120A5 JP2020544151A JP2020544151A JP2021502120A5 JP 2021502120 A5 JP2021502120 A5 JP 2021502120A5 JP 2020544151 A JP2020544151 A JP 2020544151A JP 2020544151 A JP2020544151 A JP 2020544151A JP 2021502120 A5 JP2021502120 A5 JP 2021502120A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- strand
- acid according
- nucleotides
- formula
- Prior art date
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17201449.0A EP3483270A1 (en) | 2017-11-13 | 2017-11-13 | Products and compositions |
| EP17201449.0 | 2017-11-13 | ||
| EP18179175.7 | 2018-06-21 | ||
| EP18179175.7A EP3483271A3 (en) | 2017-11-13 | 2018-06-21 | Products and compositions |
| GB201815915 | 2018-09-28 | ||
| GB1815915.2 | 2018-09-28 | ||
| PCT/EP2018/081106 WO2019092283A1 (en) | 2017-11-13 | 2018-11-13 | Nucleic acids for inhibiting expression of lpa in a cell |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021502120A JP2021502120A (ja) | 2021-01-28 |
| JP2021502120A5 true JP2021502120A5 (https=) | 2022-08-25 |
| JPWO2019092283A5 JPWO2019092283A5 (https=) | 2022-08-25 |
| JP7245254B2 JP7245254B2 (ja) | 2023-03-23 |
Family
ID=66439085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544151A Active JP7245254B2 (ja) | 2017-11-13 | 2018-11-13 | 細胞におけるｌｐａの発現を抑制するための核酸 |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US11319537B2 (https=) |
| EP (2) | EP3710586B1 (https=) |
| JP (1) | JP7245254B2 (https=) |
| KR (1) | KR102553382B1 (https=) |
| CN (2) | CN111465694A (https=) |
| AU (1) | AU2018363840B2 (https=) |
| BR (1) | BR112020009152A2 (https=) |
| CA (1) | CA3081905C (https=) |
| DK (1) | DK3710586T3 (https=) |
| ES (1) | ES2938193T3 (https=) |
| FI (1) | FI3710586T3 (https=) |
| HR (1) | HRP20230127T1 (https=) |
| HU (1) | HUE061265T2 (https=) |
| IL (1) | IL274503B2 (https=) |
| LT (1) | LT3710586T (https=) |
| MX (1) | MX2020004897A (https=) |
| PL (1) | PL3710586T3 (https=) |
| RS (1) | RS63955B1 (https=) |
| SG (1) | SG11202003230UA (https=) |
| SI (1) | SI3710586T1 (https=) |
| WO (1) | WO2019092283A1 (https=) |
| ZA (1) | ZA202003371B (https=) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE065423T2 (hu) | 2015-12-16 | 2024-05-28 | 6K Inc | Eljárás szferoidális dehidrogénezett titánötvözet részecskék elõállítására |
| US10987735B2 (en) | 2015-12-16 | 2021-04-27 | 6K Inc. | Spheroidal titanium metallic powders with custom microstructures |
| JP7155239B2 (ja) * | 2017-04-05 | 2022-10-18 | サイレンス・セラピューティクス・ゲーエムベーハー | 産物及び組成物 |
| MX2020004897A (es) | 2017-11-13 | 2020-10-05 | Silence Therapeutics Gmbh | Acidos nucleicos para inhibir la expresion de lpa en una celula. |
| WO2019143621A1 (en) | 2018-01-16 | 2019-07-25 | Dicerna Pharmaceuticals, Inc. | Compositions and methods for inhibiting aldh2 expression |
| AU2019290663B2 (en) | 2018-06-19 | 2023-05-04 | 6K Inc. | Process for producing spheroidized powder from feedstock materials |
| BR112021009213A2 (pt) * | 2018-11-13 | 2021-08-10 | Silence Therapeutics Gmbh | ácidos nucleicos para inibição da expressão de lpa em uma célula |
| CA3135402A1 (en) * | 2019-04-04 | 2020-10-08 | Dicerna Pharmaceuticals, Inc. | Compositions and methods for inhibiting gene expression in the central nervous system |
| CA3134573A1 (en) | 2019-04-30 | 2020-11-05 | Sunil Bhalchandra BADWE | Mechanically alloyed powder feedstock |
| WO2021118762A1 (en) | 2019-11-18 | 2021-06-17 | 6K Inc. | Unique feedstocks for spherical powders and methods of manufacturing |
| US20230078200A1 (en) * | 2019-12-09 | 2023-03-16 | Amgen Inc. | RNAi CONSTRUCTS AND METHODS FOR INHIBITING LPA EXPRESSION |
| AU2021297476A1 (en) | 2020-06-25 | 2022-12-15 | 6K Inc. | Microcomposite alloy structure |
| KR102812602B1 (ko) | 2020-08-05 | 2025-05-28 | 다이서나 파마수이티컬, 인크. | Lpa 발현을 저해하기 위한 조성물 및 방법 |
| AU2021349358A1 (en) | 2020-09-24 | 2023-02-09 | 6K Inc. | Systems, devices, and methods for starting plasma |
| US20240035029A1 (en) * | 2020-10-16 | 2024-02-01 | Sanofi | Rna compositions and methods for inhibiting lipoprotein(a) |
| EP4237174A1 (en) | 2020-10-30 | 2023-09-06 | 6K Inc. | Systems and methods for synthesis of spheroidized metal powders |
| WO2022098841A1 (en) * | 2020-11-05 | 2022-05-12 | Amgen Inc. | METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS |
| US20250304966A1 (en) | 2020-12-23 | 2025-10-02 | Argonaute RNA Limited | Treatment of cardiovascular disease |
| EP4275239A4 (en) | 2021-01-11 | 2024-12-18 | 6K Inc. | METHODS AND SYSTEMS FOR RECLAIMING LI-ION CATHODE MATERIALS USING MICROWAVE PLASMA TREATMENT |
| AU2022246797A1 (en) | 2021-03-31 | 2023-10-05 | 6K Inc. | Systems and methods for additive manufacturing of metal nitride ceramics |
| WO2023041508A2 (en) | 2021-09-14 | 2023-03-23 | Argonaute RNA Limited | Treatment of cardiovascular disease |
| IL312811A (en) | 2021-11-16 | 2024-07-01 | Shanghai Argo Biopharmaceutical Co Ltd | Composition and method for inhibiting angiotensinogen (agt) protein expression |
| IL312743A (en) * | 2021-11-18 | 2024-07-01 | Novartis Ag | Compounds targeting PMP22 for the treatment of Charcot-Marie-Shen disease |
| PE20241340A1 (es) | 2021-11-24 | 2024-07-03 | Adarx Pharmaceuticals Inc | Composiciones moduladoras de complemento del factor b y metodos de uso de estas |
| TW202345865A (zh) * | 2022-01-24 | 2023-12-01 | 大陸商上海舶望製藥有限公司 | 抑制LPA(Apo(a))蛋白表達的組合物和方法 |
| CN114703184B (zh) * | 2022-03-11 | 2024-06-18 | 厦门甘宝利生物医药有限公司 | Lpa抑制剂及其用途 |
| EP4522742A2 (en) | 2022-05-13 | 2025-03-19 | Alnylam Pharmaceuticals, Inc. | Single-stranded loop oligonucleotides |
| WO2023229928A1 (en) | 2022-05-23 | 2023-11-30 | 6K Inc. | Microwave plasma apparatus and methods for processing materials using an interior liner |
| US12040162B2 (en) | 2022-06-09 | 2024-07-16 | 6K Inc. | Plasma apparatus and methods for processing feed material utilizing an upstream swirl module and composite gas flows |
| WO2024006999A2 (en) | 2022-06-30 | 2024-01-04 | Alnylam Pharmaceuticals, Inc. | Cyclic-disulfide modified phosphate based oligonucleotide prodrugs |
| WO2024044498A1 (en) | 2022-08-25 | 2024-02-29 | 6K Inc. | Plasma apparatus and methods for processing feed material utilizing a powder ingress preventor (pip) |
| CN115851723B (zh) * | 2022-10-24 | 2023-10-03 | 厦门甘宝利生物医药有限公司 | 一种抑制lpa基因表达的rna抑制剂及其应用 |
| US12195338B2 (en) | 2022-12-15 | 2025-01-14 | 6K Inc. | Systems, methods, and device for pyrolysis of methane in a microwave plasma for hydrogen and structured carbon powder production |
| IL321855A (en) * | 2023-01-13 | 2025-08-01 | Lilly Co Eli | Pharmaceutical preparations containing therapeutic oligonucleotides and dosage regimens using the same |
| WO2024238385A2 (en) | 2023-05-12 | 2024-11-21 | Alnylam Pharmaceuticals, Inc. | Single-stranded loop oligonucleotides |
| WO2024240056A1 (zh) | 2023-05-19 | 2024-11-28 | 深圳信立泰药业股份有限公司 | 一种磺酰胺类化合物及其制备方法和医药用途 |
| CN119563025A (zh) | 2023-07-04 | 2025-03-04 | 石药集团中奇制药技术（石家庄）有限公司 | 一种抑制LP(a)基因表达的dsRNA分子及其应用 |
| WO2025082058A1 (zh) * | 2023-10-16 | 2025-04-24 | 润佳(上海)医药技术有限公司 | 一种抑制LPA基因表达的dsRNA及其用途 |
| WO2025103391A1 (zh) * | 2023-11-15 | 2025-05-22 | 北京加科瑞康医药科技有限公司 | 用于抑制lpa的基因表达的sirna，含其的组合物及其用途 |
| CN120098993A (zh) * | 2023-12-05 | 2025-06-06 | 广东东阳光药业股份有限公司 | 一种新型的双链siRNA、其缀合物及其用途 |
| WO2026008063A1 (en) * | 2024-07-05 | 2026-01-08 | Geneditbio Limited | Methods and compositions for lpa gene editing and therapy using crispr system |
| WO2026046152A1 (zh) * | 2024-08-26 | 2026-03-05 | 倍臻生物技术（苏州）有限公司 | 修饰的双链核糖核酸及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9201440A (nl) | 1992-08-11 | 1994-03-01 | Univ Leiden | Triantennaire clusterglycosiden, hun bereiding en toepassing. |
| US7227014B2 (en) | 2001-08-07 | 2007-06-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein (a) expression |
| US7259150B2 (en) | 2001-08-07 | 2007-08-21 | Isis Pharmaceuticals, Inc. | Modulation of apolipoprotein (a) expression |
| US20060160759A1 (en) * | 2002-09-28 | 2006-07-20 | Jianzhu Chen | Influenza therapeutic |
| US20110110886A1 (en) * | 2008-06-13 | 2011-05-12 | Yale University | Small molecule inhibitors of autotaxin and methods of use |
| CN108148838A (zh) * | 2012-05-22 | 2018-06-12 | 奥利克斯医药有限公司 | 具有细胞内穿透能力的诱导rna干扰的核酸分子及用途 |
| US20160272970A1 (en) * | 2015-03-17 | 2016-09-22 | Arrowhead Madison Inc. | RNA Interference Agents |
| JOP20160211B1 (ar) * | 2015-10-01 | 2021-08-17 | Arrowhead Pharmaceuticals Inc | تراكيب وأساليب لتثبيط تعبير جيني للـ lpa |
| EP3228326A1 (en) * | 2016-04-05 | 2017-10-11 | Silence Therapeutics GmbH | Nucleic acid linked to a trivalent glycoconjugate |
| JP7155239B2 (ja) | 2017-04-05 | 2022-10-18 | サイレンス・セラピューティクス・ゲーエムベーハー | 産物及び組成物 |
| CA3118327A1 (en) | 2017-11-13 | 2019-05-16 | Silence Therapeutics Gmbh | Nucleic acids for inhibiting expression of aldh2 in a cell |
| MX2020004897A (es) | 2017-11-13 | 2020-10-05 | Silence Therapeutics Gmbh | Acidos nucleicos para inhibir la expresion de lpa en una celula. |
| BR112021009213A2 (pt) | 2018-11-13 | 2021-08-10 | Silence Therapeutics Gmbh | ácidos nucleicos para inibição da expressão de lpa em uma célula |
-
2018
- 2018-11-13 MX MX2020004897A patent/MX2020004897A/es unknown
- 2018-11-13 CN CN201880073189.3A patent/CN111465694A/zh active Pending
- 2018-11-13 CN CN202411317688.6A patent/CN119120476A/zh active Pending
- 2018-11-13 DK DK18803644.6T patent/DK3710586T3/da active
- 2018-11-13 HR HRP20230127TT patent/HRP20230127T1/hr unknown
- 2018-11-13 IL IL274503A patent/IL274503B2/en unknown
- 2018-11-13 RS RS20230097A patent/RS63955B1/sr unknown
- 2018-11-13 SG SG11202003230UA patent/SG11202003230UA/en unknown
- 2018-11-13 FI FIEP18803644.6T patent/FI3710586T3/fi active
- 2018-11-13 LT LTEPPCT/EP2018/081106T patent/LT3710586T/lt unknown
- 2018-11-13 EP EP18803644.6A patent/EP3710586B1/en active Active
- 2018-11-13 US US16/763,458 patent/US11319537B2/en active Active
- 2018-11-13 HU HUE18803644A patent/HUE061265T2/hu unknown
- 2018-11-13 PL PL18803644.6T patent/PL3710586T3/pl unknown
- 2018-11-13 CA CA3081905A patent/CA3081905C/en active Active
- 2018-11-13 BR BR112020009152-9A patent/BR112020009152A2/pt not_active Application Discontinuation
- 2018-11-13 AU AU2018363840A patent/AU2018363840B2/en active Active
- 2018-11-13 EP EP22208120.0A patent/EP4219716A3/en active Pending
- 2018-11-13 ES ES18803644T patent/ES2938193T3/es active Active
- 2018-11-13 WO PCT/EP2018/081106 patent/WO2019092283A1/en not_active Ceased
- 2018-11-13 KR KR1020207016884A patent/KR102553382B1/ko active Active
- 2018-11-13 JP JP2020544151A patent/JP7245254B2/ja active Active
- 2018-11-13 SI SI201830845T patent/SI3710586T1/sl unknown
-
2020
- 2020-06-05 ZA ZA2020/03371A patent/ZA202003371B/en unknown
-
2022
- 2022-03-17 US US17/697,405 patent/US12054717B2/en active Active
-
2024
- 2024-06-17 US US18/745,632 patent/US20240327843A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502120A5 (https=) | ||
| JPWO2019092283A5 (https=) | ||
| JP2022507282A5 (https=) | ||
| IL274503B2 (en) | Nucleic acids for inhibiting expression of lpa in a cell | |
| JP2024028453A5 (https=) | ||
| JP2019503394A5 (https=) | ||
| FI3880818T3 (fi) | Nukleiinihappoja LPA:n ekspression inhiboimiseksi solussa | |
| CN113795582A (zh) | 核酸、药物组合物与缀合物及制备方法和用途 | |
| JP2023068035A5 (https=) | ||
| JP2007504830A5 (https=) | ||
| JP2016520312A5 (https=) | ||
| JP2021529173A5 (https=) | ||
| FI3688162T3 (fi) | Formulaatioita | |
| JP2021533804A5 (https=) | ||
| JP2020534268A (ja) | アンジオポエチン様３（ＡＮＧＰＴＬ３）の発現を阻害するためのＲＮＡｉ剤および組成物、ならびに使用方法 | |
| JP2016523087A5 (https=) | ||
| JP2021533800A5 (https=) | ||
| CN113330117A (zh) | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 | |
| TWI268279B (en) | Dimeric anti-viral agents and methods for preparation and use thereof | |
| JP2022501059A5 (https=) | ||
| JPWO2021030778A5 (https=) | ||
| JP2009514877A5 (https=) | ||
| RU2013107129A (ru) | Модуляция экспрессии timp1 и timp2 | |
| JPWO2020099476A5 (https=) | ||
| JPH09506770A (ja) | ｃ−ｅｒｂＢの発現が関与する疾患を予防及び治療するためのアンチセンス核酸 |